Zacks Investment Research on MSN
FLGT to acquire Bako & StrataDx assets to expand pathology platform
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire ...
The diagnostic armamentarium for solid tumors is evolving rapidly, redefining how we detect, stage, stratify, monitor, and ultimately treat cancer. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback